Convalescent plasma therapy as a treatment for COVID-19 [electronic resource] / Manu Shankar-Hari.
Material type:
SoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2020Description: 1 online resource (1 streaming audio file (15 min.))Subject(s): Blood plasma | Clinical trials | Coronavirus infections -- Treatment | COVID-19 (Disease) -- Treatment | Viral antibodies | Antibodies, Viral -- administration & dosage | Antibodies, Viral -- blood | Antibodies, Viral -- therapeutic use | Betacoronavirus -- immunology | Blood Donors | Clinical Trials as Topic | Coronavirus infections | COVID-19 -- blood | COVID-19 -- immunology | COVID-19 -- therapy | Immunization, Passive | Pneumonia, Viral -- prevention & control | Pneumonia, Viral -- therapy | SARS-CoV-2Online resources: Click here to access online | Series Audio interview.
Title from title frames.
Contents: What is convalescent plasma therapy -- Does this treatment confer long-lasting immunity? -- Mechanism of action of therapeutic antibodies -- Counterindications with plasma transfusions -- The need for lengthy clinical trials -- Preliminary assessment of convalescent plasma therapy in a clinical trial -- When might this treatment be approved, and how fast can it be delivered?.
Access restricted to subscribers.
Mode of access: World Wide Web.